Gene Therapy Research Characterization Using DLS and Zeta Potential
contributed by Malvern Panalytical |
The use of zeta potential and DLS measurements in gene therapy research
The use of antibodies, either covalently attached onto the surface of neutral and anionic liposomes or used in a complex, is also being investigated. Zeta potential measurements are being used to develop the most efficient formulations of liposomes, peptides, DNA complexes for transfection studies in vivo and in vitro.
Gene therapy is the process by which genetic material is delivered, by means of a vector, to patients for a therapeutic purpose. Vectors are delivery vehicles - usually a virus or a liposome - used to transport the genetic material to target cells in the body.
Both cationic and anionic liposomes are currently being investigated as vectors for gene therapy and their effectiveness in transfection is being studied by research groups and pharmaceutical companies.
Cationic liposomes (positively charged) are complexed with DNA (plasmids) Fig. 1. The liposome:DNA ratio is seen to be essential for optimal transfection.
Zeta potential measurements can be used to optimise the ratio required for particular liposomes with various plasmids Fig 2. The plot also shows the zaverage diameters of the complex formed at various plasmid:liposome ratios obtained from photon correlation spectroscopy (PCS) measurements. When the complex has either a high negative or positive zeta potential, the size is around 90nm.
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.